SpecialeAnalysis

Biogen testing channel support

NASDAQ:BIIB   Biogen Inc.
Biogen Inc. (BIIB) currently testing channel support, able to absorb weekly selling pressures.

From here, (BIIB) can recover and turn higher to channel resistance, eliciting gains of 20-25% over the following 2 - 3 months.

A settlement above this week’s high would accelerate this upward momentum.

Inversely, closing below this channel support would indicate losses of 20% over the following 2 - 3 months where (BIIB) can bottom out into Q4.

Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。